SARS-CoV-2-specific CD4⁺ T cell longevity correlates with Th17-like phenotype

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Understanding long-term immune memory after SARS-CoV-2 infection is crucial for predicting immunity duration.
• Phenotypes of memory T-cells, antibody levels, and their relationship with disease severity require further elucidation.

Purpose of the Study:

• To investigate the determinants of memory T-cell longevity post-SARS-CoV-2 infection.
• To explore the association between T-cell phenotypes, antibody titers, and COVID-19 disease severity.

Main Methods:

• Longitudinal analysis of SARS-CoV-2-specific T-cell and antibody responses.
• Categorization of CD4+ T-cells into Th1, Th2, Th17, and Tfh-like subsets.
• Comparison of T-cell half-lives and antibody titers across mild, moderate, and severe COVID-19 cases.

Main Results:

• CD4+ and CD8+ T-cells exhibited longer half-lives than antibodies, independent of disease severity.
• The Th17-like CD4+ T-cell subset demonstrated the longest half-life, correlating with T-cell longevity.
• Th2-like and Tfh-like T-cells were more strongly associated with antibody titers.

Conclusions:

• Distinct CD4+ T-cell subsets play differential roles in maintaining long-term immunity and antibody responses after SARS-CoV-2 infection.
• Th17-like cells are key drivers of T-cell memory longevity, while Th2 and Tfh-like cells are linked to humoral immunity.